Stock scanner
Ready-made scans
Fastest expected revenue growth under $2BCheap and profitableDividend payersNear their 52-week highBeaten down, finances improvingReporting this week
Filters
5,450 US-listed companies, filtered by valuation, profitability, growth, analysts' forecasts and momentum. Prices are from the October 9 close; company figures refresh weekly.
This data is 9 days old: the nightly update hasn't run since October 10.
The scanner turns your question into filters, and the results come straight from the data. The filters it chose show below, to check or change. You get 3 free questions a month.
5,450 companies match
| Company | Mkt cap | Price | P/E | EV/Sales | P/B | Yield | Net margin | ROIC | Rev growth | 1Y |
|---|---|---|---|---|---|---|---|---|---|---|
| LSBKLake Shore Bancorp, Inc. | $144M | $18.25 | 16.3 | n/a | 0.9 | 2.0% | 20.7% | n/a | 5.6% | +41.7% |
| CTWCTW Cayman Class A Ordinary Shares | $144M | $2.30 | 36.0 | 1.5 | 5.0 | 0.0% | 4.2% | −2.0% | 32.1% | +2.2% |
| COOKTraeger, Inc. | $144M | $51.60 | loss | 1.0 | 0.8 | 0.0% | −23.2% | −0.8% | −16.3% | +4.2% |
| RNAAtrium Therapeutics, Inc. | $144M | $8.40 | loss | 3.1 | 0.7 | 0.0% | −397% | −38.4% | — | −43.1% |
| MOLNMolecular Partners AG | $144M | $3.85 | loss | — | 2.0 | 0.0% | — | −76.9% | −100% | +1.3% |
| OZBelpointe PREP, LLC | $145M | $37.07 | loss | 27.1 | 0.6 | 0.0% | −290% | −2.9% | 164% | −42.1% |
| BREZBreeze Acquisition Corp. II | $145M | $10.05 | loss | 45.7 | — | 0.0% | −163% | −220% | — | +1.3% |
| OCLTOceanLight Acquisition Corp. | $146M | $9.90 | — | — | — | — | — | — | — | 0.0% |
| EGANeGain Corporation | $146M | $5.32 | 16.5 | 0.8 | 1.7 | 0.0% | 9.7% | 7.3% | 3.1% | −58.4% |
| VRAVera Bradley, Inc. | $146M | $5.14 | loss | 0.7 | 1.1 | 0.0% | −3.7% | −4.1% | −6.3% | +158% |
| NCOSouthern Cross Acquisition I Corp. | $147M | $9.96 | — | — | — | 0.0% | — | — | — | +1.3% |
| SKYXSKYX Platforms Corp. | $148M | $1.10 | loss | 1.6 | 7.9 | 0.0% | −34.3% | −54.5% | 8.1% | −2.7% |
| VYGRVoyager Therapeutics, Inc. | $148M | $2.45 | loss | 4.2 | 1.0 | 0.0% | −313% | −62.4% | −19.1% | −51.0% |
| NERVMinerva Neurosciences, Inc. | $148M | $3.18 | loss | — | neg. eq. | 0.0% | — | −38.6% | — | +35.3% |
| DLTHDuluth Holdings Inc. | $148M | $3.90 | 24.4 | 0.5 | 0.8 | 0.0% | 1.1% | 4.0% | −8.6% | +20.0% |
| STIMNeuronetics, Inc. | $148M | $2.13 | loss | 1.4 | 8.5 | 0.0% | −19.6% | −21.1% | 39.6% | −23.7% |
| EMLThe Eastern Company | $148M | $24.59 | 18.4 | 0.8 | 1.1 | 1.8% | 3.4% | 2.1% | −13.7% | +15.7% |
| SIFSIFCO Industries, Inc. | $149M | $23.75 | 36.9 | 1.7 | 3.5 | 0.0% | 4.0% | 8.1% | 53.4% | +244% |
| WWWW International, Inc. | $149M | $14.86 | loss | 0.7 | 0.5 | 0.0% | −14.8% | −3.0% | −8.7% | −42.9% |
| NAKANakamoto Inc. | $149M | $8.54 | loss | n/a | 0.7 | 0.0% | −1068% | n/a | 1658% | −75.5% |
| FINWFinWise Bancorp | $151M | $10.99 | 10.7 | n/a | 0.7 | 0.0% | 6.8% | n/a | 88.8% | −39.8% |
| WHFWhiteHorse Finance, Inc. | $151M | $7.02 | 8.9 | 9.5 | 0.6 | 14.9% | 37.2% | 3.7% | 33.6% | +7.5% |
| FEAM5E Advanced Materials Inc. | $151M | $3.64 | loss | — | 2.4 | 0.0% | — | −63.9% | — | −35.7% |
| CDXSCodexis, Inc. | $152M | $1.41 | loss | 2.5 | 3.9 | 0.0% | −39.6% | −22.7% | 35.9% | −45.6% |
| IPHAInnate Pharma S.A. | $152M | $1.62 | loss | 137 | neg. eq. | 0.0% | −4554% | −381% | −77.9% | −20.2% |
| TOROToro Corp. | $152M | $4.41 | 47.4 | 3.3 | 0.3 | 60.1% | 22.7% | −1.4% | −0.0% | +6.0% |
| CCAQCollective Acquisition Corp. | $154M | $10.60 | 57.1 | — | 1.1 | 0.0% | — | −1.2% | — | +4.6% |
| HTLMHomesToLife Ltd | $154M | $1.72 | 1.8 | 0.3 | 6.5 | 3.8% | 4.3% | 57.3% | — | −48.1% |
| BETRBetter Home & Finance Holding Company | $155M | $9.86 | loss | n/a | 3.2 | 0.0% | −85.0% | n/a | 32.2% | −82.7% |
| QTRXQuanterix Corporation | $155M | $3.28 | loss | 0.9 | 0.6 | 0.0% | −80.3% | −46.9% | 23.4% | −41.8% |
| NIUNiu Technologies | $155M | $1.97 | loss | 0.0 | 1.5 | 0.0% | −4.3% | −22.8% | 24.5% | −58.3% |
| ABOSAcumen Pharmaceuticals, Inc. | $155M | $2.14 | loss | — | 2.7 | 0.0% | — | −119% | — | 0.0% |
| TONTGraf Global Corp. | $155M | $10.93 | — | — | — | 0.0% | — | — | — | +1.3% |
| TARAProtara Therapeutics, Inc. | $155M | $2.76 | loss | — | 1.0 | 0.0% | — | −46.8% | — | −47.2% |
| OPRXOptimizeRx Corp. | $155M | $8.28 | 34.0 | 1.5 | 1.2 | 0.0% | 4.7% | 4.9% | −5.8% | −54.2% |
| ONEWOneWater Marine Inc. | $155M | $9.35 | loss | 0.5 | 0.5 | 0.0% | −6.7% | 4.6% | 1.3% | −36.6% |
| EHEHang Holdings Limited | $155M | $4.19 | loss | 4.1 | 1.2 | 0.0% | −107% | −27.1% | −25.3% | −75.7% |
| SIDUSidus Space, Inc. | $156M | $1.55 | loss | — | 0.7 | 0.0% | −970% | −14.6% | −32.6% | +28.1% |
| ELMEElme Communities | $156M | $1.76 | loss | — | 0.9 | 844% | 125% | −338% | −150% | −89.4% |
| FOCLEDAP TMS S.A. American Depositary Shares | $157M | $4.19 | loss | 2.5 | neg. eq. | 0.0% | −56.2% | −68.7% | 2.0% | +102% |
| ANTXAN2 Therapeutics, Inc. | $158M | $4.40 | loss | — | 2.6 | 0.0% | — | −51.0% | — | +249% |
| KRSAKorsana Biosciences, Inc. | $159M | $33.92 | loss | 82.8 | 4.0 | 0.0% | −353% | −134% | −12.6% | +108% |
| RRGBRed Robin Gourmet Burgers, Inc. | $159M | $8.61 | loss | 0.5 | neg. eq. | 0.0% | −2.5% | −1.1% | −3.1% | +36.2% |
| MENSJyong Biotech Ltd. Ordinary Shares | $160M | $2.10 | loss | — | neg. eq. | 0.0% | — | 46.0% | — | −96.2% |
| SSTKShutterstock, Inc. | $160M | $4.35 | loss | 0.3 | 0.4 | 31.7% | −22.9% | −23.0% | −10.8% | −79.6% |
| MRTMarti Technologies, Inc. | $160M | $1.86 | loss | 4.2 | neg. eq. | 0.0% | −69.8% | −45.0% | 145% | −19.5% |
| EMPEntergy Mississippi, Inc. 1M BD 66 | $160M | $18.51 | 4.7 | 1.4 | 2.5 | 6.6% | 17.2% | 5.2% | 16.5% | −13.7% |
| DPRODraganfly Inc. | $161M | $4.40 | loss | 10.3 | 1.5 | 0.0% | −359% | −24.2% | 26.3% | −63.4% |
| NBPNovaBridge Biosciences | $161M | $1.40 | loss | — | 0.8 | 0.0% | — | −29.0% | — | −70.8% |
| ENHAEnhanced Group Inc. Class A | $161M | $1.25 | loss | 8.0 | 48.1 | 0.0% | −441% | −173% | — | −87.8% |
Showing 1,551–1,600 of 5,450
A blank means a figure isn't reported or doesn't mean anything for that company: there's no P/E for a company losing money, no EV/Sales for a bank, no P/B when a company owes more than it owns. A filter on that figure leaves the company out. Growth compares the last twelve months with the twelve before. Figures describe the companies; they aren't advice to buy or sell anything.